Preview

"Arterial’naya Gipertenziya" ("Arterial Hypertension")

Advanced search

Optimization of cardioprotection using intermittent isothermic blood-cardioplegia

https://doi.org/10.18705/1607-419X-2009-15-2-138-141

Abstract

Objective. The aim of this research was to optimize cardioprotection by means of isothermal intermittent blood cardioplegia in patients with left ventricle myocardial hypertrophy (LVMH). Materials and methods. We analyzed 700 pair samples of transmyocardial blood, taken from 100 patients divided into two groups: research group with LVMH (n = 50, left ventricle posterior wall ≥ 11 mm), and control group without LVMH (n = 50, LVPW < 11 mm). The comparison of average levels of transmyocardial lactate, venous saturation, pH, oxygen consumption, venous carbon dioxide tension (pvCO2) initially and at the end of each cardioplegia depending on its time and volume parameters was carried out in each group with the use of Student and Wilkokson criteria. Results. Average cross clump time and the number of cardioplegia sessions in research and control groups had no significant differences (37,7 ± 12,8 and 38,9 ± 24,8 minutes; 3,1 ± 2,2 and 3,5 ± 3,1 sessions accordingly; p > 0,05). If the intervals between cardioplegia sessions were 12-15 minutes the average transmyocardial lactate level was significantly higher in research group (2,2 ± 1,7 and 1,6 ± 1,1 mmol/l; p < 0,05), if the intervals were more than 15 minutes the changes were even more expressed (2,5 ± 1,9 and 1,7 ± 0,9 mmol/l; p < 0,05). When the maintenance coronary sinus lactate level was less than 2,2 mmol/l in both groups, average time between cardioplegia sessions was 11,3 ± 5,9 minutes and was significantly lower, than in group with compromised myocardium metabolism. Conclusion. Our data show that the quality of cardioprotection depends on LVMH presence and cardioplegia volume-time characteristics.

About the Authors

D. Botkin
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. V. Naumushin
Almazov federal heart, blood and endocrinology centre
Russian Federation


M. L. Gordeev
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. E. Bautin
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. P. Mikhailov
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. Y. Bakanov
Almazov federal heart, blood and endocrinology centre
Russian Federation


D. I. Kurapeev
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. N. Kotin
Almazov federal heart, blood and endocrinology centre
Russian Federation


A. S. Gnevashev
Almazov federal heart, blood and endocrinology centre
Russian Federation


References

1. Бокерия Л.А., Мовсесян Р.Р., Мусина Р.А. Актуальные вопросы интраоперационной защиты миокарда (кардиоплегия) // Грудная и сердечно-сосудистая хирургия. - 1998. - № 5. - С. 63.

2.

3. Малашенков А.И. Сравнительная оценка методов защиты миокарда при операциях с искусственным кровообращением: Автореф. дис… докт. мед. наук. - М., 1982.

4.

5. Худоногова С.В., Курапеев И.С., Наймушин А.В., Гордеев М.Л. Сравнительная оценка защиты миокарда методами кровяной и кристаллоидной кардиоплегии у больных с высоким риском операции коронарного шунтирования // Вестн. хир. - 2002. - Т. 161, № 5. - С. 19-22.

6.

7. Худоногова С.В., Рубинчик В.Е., Наймушин А.В. и др. Результаты использования кровяной кардиоплегии у больных ишемической болезнью сердца со сниженной сократительной способностью миокарда // Материалы 3 Всероссийского съезда по экстракорпоральным технологиям. - Суздаль. - 2001. - С. 19.

8.

9. Albert A.A., Arnrich B., Walter J.A. et al. Hyperkalemic blood versus crystalloid cardioplegia in longer clamping times // Asian Cardiovasc. Thorac. Ann. - 2004. - Vol. 12, № 2. - P. 115-120.

10.

11. Allen B.S. Pediatric myocardial protection: where do we stand? // J. Thorac. Cardiovasc. Surg. - 2004. - Vol. 128, № 1. - P. 67-75.

12.

13. Ascione R., Caputo M., Gomes W.J. et al. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia // Eur. J. Cardiothorac. Surg. - 2002. - Vol. 21, № 3. - P. 440-446.

14.

15. Bouchart F., Bessou J.P., Tabley A. et al. How to protect hypertrophied myocardium? A prospective clinical trial of three preservation techniques // Int. J. Artif. Organs. - 1997. - Vol. 20, № 8. - P. 440-446.

16.

17. Brandrup W.G., Haglid M., Karlsson T. Et al. Preoperative risk indicators of death at an early and late stage after coronary artery bypass grafting // Thorac. Cardiovasc. Surg. - 1995. - Vol.43, № 2. - P.77-82.

18.

19. Buckberg C.D. Antegrade/Retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives // J. Cardiac. Surg. - 1989. - Vol. 4, № 3. - P. 216-238.

20.

21. Buckberg G.D., Dyson C.W., Emerson R.C. Technique for administering clinical cardioplegia // A textbook of clinical cardioplegia - N.Y., 1982. - P. 305-316.

22.

23. Catinella F.P., Cunningham J.N. Jr., Spencer F.C. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia // J. Thorac. Cardiovasc. Surg. - 1984. - Vol. 88, № 3. - P. 411-423.

24.

25. Feng J., Bianchi C., Li J., Sellke F.W. Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia // Ann. Thorac. Surg. - 2004. - Vol. 77, № 4. - P. 1384-1389; discussion 1389-1390.

26.

27. Ferreira R., Fraga C., Carrasquedo F. et al. Comparison between warm blood and crystalloid cardioplegia during open heart surgery // Int. J. Cardiol. - 2003. - Vol. 90, № 2-3. - P. 253-260.

28.

29. Gasior Z., Krejca M., Szmagala P. et al. Long term left ventricular systolic function assessment following CABG. A prospective, randomized study. Blood versus crystalloid cardioplegia // J. Cardiovasc. Surg. (Torino). - 2000. - Vol. 41, № 5. - P. 695-702.

30.

31. Laks H., Barner H.B., Kaiser G. Cold blood cardioplegia // J. Thorac. Cardiovasc. Surg. - 1979. - Vol. 77, № 2. - P. 319-322.

32.

33. Lichtenstein S. V. Warm heart surgery: concept, concerns, and future course // J. Cardiac Surg. - 1993. - Vol. 8, № 2. - P. 161-166.

34.

35. Øvrum E., Tangen G., Tølløfsrud S. et al. Cold blood cardioplegia versus cold crystalloid cardioplegia: a prospective randomized study of 1440 patients undergoing coronary artery bypass grafting // J. Thorac. Cardiovasc. Surg. - 2004. - Vol. 128, № 6. - P. 860-865.

36.

37. Rinne T., Pehkonen E., Kaukinen S., Tarkka M. Comparison of cardioprotection with crystalloid and blood cardioplegia in CABG patients // J. Thorac. Cardiovasc. Surg. - 1993. - Vol. 7, № 6. - P. 679-683.

38.


Review

For citations:


Botkin D., Naumushin A.V., Gordeev M.L., Bautin A.E., Mikhailov A.P., Bakanov A.Y., Kurapeev D.I., Kotin A.N., Gnevashev A.S. Optimization of cardioprotection using intermittent isothermic blood-cardioplegia. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(2):138-141. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-2-138-141

Views: 943


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)